Adding a data point of agreement rather than a data point.
Washout: how long is long enough, and for what purpose
I had read the opposite somewhere and cannot now find where, which tells me something.
Checked the washout claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope.
Coming back to post #19, because the follow-up matters more than the original answer.
Where I have landed on washout, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has borrowed it from somewhere that did not measure it.
Thank you for taking the time. That was more work than a reply usually is.
I had written a reply contradicting post #29 and deleted it. Here is what survived.
Metabolism for peptide drugs is proteolytic rather than hepatic in the usual sense, which is why the cytochrome interaction questions that dominate small-molecule pharmacology mostly do not apply.
Written quickly, so the reasoning may be tighter than the wording.
Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady state and how long it takes to clear after stopping.
That is a fair summary of where the discussion has got to.
Read the full topic (71 posts)
This topic was referenced in
- Half-life, steady state, and accumulation worked throughPharmacology › Pharmacokinetics · 130 replies
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Clearance pathways and what renal impairment changes
Clearance pathways and what renal impairment changes Writing it up because I had to work it out twice and would rather nobody else did. What changes if the standard account of clearance pathways is wrong? I…
|
+11 | 15 | 43k | 2mo |
|
About the Pharmacokinetics category
Half-life, accumulation, steady state, albumin binding, and why weekly dosing works. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author…
|
4 | 32k | 8mo | |
|
Peak-to-trough ratio at steady state for a weekly agent — the long version
Peak-to-trough ratio at steady state for a weekly agent — the long version Writing it up because I had to work it out twice and would rather nobody else did. A narrow question about Peak-to-trough ratio,…
|
+57 | 61 | 708 | 1d |
|
Half-life, steady state, and accumulation worked through — a second dataset
Half-life, steady state, and accumulation worked through — a second dataset — setting out what I have, and where I think it stops being reliable. Working through the kinetics rather than the pharmacology,…
|
+110 | 126 | 14k | 4mo |
|
Coming back to: Washout: how long is long enough, and for what purpose
Posting this under the heading it deserves: Washout: how long is long enough, and for what purpose Everything below is what sits behind that. A narrow question about Washout, deliberately narrow, because the…
|
+128 | 139 | 3k | 3mo |
Related topics — sharing the tags semaglutide, missed dose, worked example
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
A 10 mg vial reconstituted three different ways, compared — the long version
A 10 mg vial reconstituted three different ways, compared — the long version — setting out what I have, and where I think it stops being reliable. Asking about 10 mg vial reconstituted three directly, because…
|
+146 | 158 | 47k | 9mo |
|
Follow-up: How to disagree with an answer you were given, well
How to disagree with an answer you were given, well I have a specific reason for asking rather than idle curiosity, and the context is below. Question in the title and the context underneath, in the order the…
|
2 | 16k | 30d | |
|
Reading U-100 graduations, with a conversion table — one year on
Reading U-100 graduations, with a conversion table — one year on Writing it up because I had to work it out twice and would rather nobody else did. I would like to disagree carefully with the settled view on…
|
+3 | 7 | 662 | 4mo |
|
Subcutaneous absorption kinetics and site differences
Posting this under the heading it deserves: Subcutaneous absorption kinetics and site differences Everything below is what sits behind that. Asking about subcutaneous absorption kinetics and site directly,…
|
+15 | 19 | 3.9k | 12mo |
|
The mass-error checker and its intended scope
The mass-error checker and its intended scope Writing it up because I had to work it out twice and would rather nobody else did. Proposing that mass-error checker deserves a maintained page rather than a…
|
+149 | 167 | 42k | 2y |